Mycoplasma pneumoniae, M. genitalium, M. fermentans, M. hominis, M. salivarium, M. orale, Ureaplasma urealyticum and Acholeplasma laidlawii inactivated the vascular permeability-increasing activity of bradykinin when the mixture of bradykinin and mycoplasma cells was injected after incubation at 37 °C for 1 h. Cell components responsible for inactivation of the activity of bradykinin were found to be arginine-specific aminopeptidase and carboxypeptidase. man, and at least one species, Mycoplasma pneumoniae, is proven to be pathogenic for man. The role of other Mycoplasma species in diseases of man is poorly understood. To gain an insight into the role of mycoplasmas in diseases of man, we tried to investigate the vascular permeability-increasing activity of mycoplasmas and the action of mycoplasmas on bradykinin, an important chemical mediator of the inflammatory response.
1% arginine hydrochioride for other Mycoplasma species, and the liquid medium of Taylor-Robinson et al. [2] for U. urealyticum.
The ceils from the cultures showing the maximum growth were harvested by centrifuging the cultures at 22 000 x g for 15 rain, washed 3 times, and suspended in a small volume of phosphatebuffered saline (PBS, pH 7.2).
Measurement of vascular permeability
Vascular permeability was determined in male Japanese white rabbits, weighing 2-3 kg. For all samples, a 0.1-ml aliquot was injected intracutaneously into the clipped abdominal skin. Immediately after the injection, Evans blue solution was administered intravenously (2 ml of 2.5% solution per 1 kg b. wt.) After the diameters of the blue spots produced were measured, 30 rain after the dye administration, the animal was killed by exsanguination. Then the skin was removed and its photograph was taken. Two rabbits were used for each experiment to confirm the reproducibility.
Treatment of bradykinin with mycoplasma cells
A reaction mixture containing 0.4 ml of cell suspensions (1 mg of protein per ml of PBS) unheated or heated for 40 min in boiling water and 0.2 ml of pure bradykinin (1.67 #g/ml PBS) was incubated at 37°C for 1 h. A 0.1-ml portion of the reaction mixture containing 67 fig of cell protein and 55 ng of bradykinin was assayed for vascular permeability.
Protein concentrations were determined by the method of Lowry et al. [3] as modified by Dully and Grieve [4] . 
Thin-layer chromatography (TLC)
A reaction mixture containing 100/~1 of 5 mM bradykinin and 50/~1 of cell suspensions (1 mg of protein per ml), 0.1 /~g of aminopeptidase My [5] or carboxypeptidase My [6] was incubated at 37 o C for 1 h and a 1-td portion of the reaction mixture was spotted on the precoated silica plate (HPTLC Si 50000; E. Merck AG, Darmstadt, Federal Republic of Germany). The chromatogram was processed by the method described previously [6] . 151 
RESULTS AND DISCUSSION
A preliminary experiment was carried out to determine the correlation between the vascular permeability-increasing activity [7] and the amount of bradykinin. As a result, 550, 55 and 5.5 ng of bradykinin produced blue spots, the diameters of which were 1.5 x 1.6, 0.8 x 0.9 and 0.5 x 0.6 cm, respectively (data not shown). None of the tested mycoplasmas produced blue spots when 67/~g of cell protein was injected ( Fig. 1) . Therefore, the reaction mixture for investigating effects of mycoplasma cells on the activity of bradykinin was prepared to contain 67/~g of cell protein and 55 ng of bradykinin as described in MATERIALS AND METHODS. Bradykinin produced a blue spot (0.7 x 0.8 cm), while none of the reaction mixtures of mycoplasma cells and bradykinin increased the vascular permeability (Fig. 1) . This result suggests that all mycoplasmas tested possess substances which inactivate the activity of bradykinin. To characterize them, the reaction products were analyzed by the TLC method. As shown in Fig. 2 , arginine, citrulline and ornithine were detected in the reaction mixture of bradykinin and M. fermentans as well as nonfermentative mycoplasmas, and arginine in those of bradykinin and each of U. urealyticum, M. pneumoniae, M. genitalium and A. laidlawii. In addition, aminopeptidase My and carboxypeptidase My purified from M. sali-variurn were found to release arginine from bradykinin. Therefore, the substances were considered to be exopeptidases such as aminopeptidases and carboxypeptidases, because these enzymes are known to exist in many Mycoplasma species, U. urealyticum and A. laidlawii [8] [9] [10] [11] .
The arginine released may possibly be converted to citrulline and ornithine by the arginine dihydrolase pathway [12] which is well known to exist in nonfermative mycoplasmas and M. ferrnentans [13] . This is why citrulline and ornithine are detected in the reaction mixtures. To investigate whether or not aminopeptidases and carboxypeptidases inactivate the activity of bradykinin, we purified aminopeptidase My and carboxypeptidase My from M. salivariurn by the procedures described previously [5, 6] and examined effects of these enzymes on the activity of bradykinin. It was confirmed that these enzymes inactivated the activity of bradykinin (Fig. 3) . Furthermore, the reaction mixtures of bradykinin and mycoplasma cells which had been boiled for 40 min were examined for vascular permeability. It was previously confirmed that the treatment inactivated these enzymes. As expected, all reaction mixtures were shown to produce the similar size (0.9 x 0.8 cm) of blue spots to that of bradykinin ( Fig. 4) .
On the basis of these results, the vascular permeability-increasing activity of bradykinin was supposed to be inactivated by the actions of aminopeptidases and carboxypeptidases existing in these mycoplasmas. Judging from the fact that bradykinin is an important chemical mediator of the inflammatory response, mycoplasmas might play some etiological role in the inflammation.
